查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553427

全球神經修復市場規模、佔有率和趨勢分析：按類型、技術、應用、地區和細分市場進行預測（2024-2030）

Neuroprosthetics Market Size, Share & Trends Analysis Report By Type (Motor Prosthetics, Cochlear Implants, Cognitive Prosthetics, Retinal Implants), By Technology, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

神經假體市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，2024年至2030年，全球神經修復市場預計將以15.6%的複合年成長率成長，2030年達到349億美元。神經系統疾病的日益流行，加上對具有成本效益和技術先進的植入的需求，預計將在未來幾年擴大對神經假體市場的需求。

此外，與傳統藥物治療相關的高成本和副作用也促進了植入的採用。例如，在治療阿茲海默症、腦動脈瘤和中風時，擴大採用迷走神經刺激（VNS）治療系統而不是抗憂鬱症藥，這正在推動整體市場的成長。

此外，易患癲癇的老年人口數量不斷增加，以及神經移植相對於傳統藥物治療的選擇正在對整個行業的成長產生積極影響。

神經假體市場報告亮點

  • 2023年的市場佔有率將由運動義肢裝置領域主導，佔比超過42.8.0%，其次是視覺人工電子耳。同時，由於滲透率不斷上升以及產品創新方面研發力度的加大，視網膜神經修復術已被確定為成長最快的細分市場之一。
  • 脊髓刺激（SCS）部分佔最大佔有率，超過49.2%，因為SCS療法用於治療缺血性疼痛、背部手術失敗症候群和複雜難治性疼痛症候群的鎮痛特性。此外，它也被應用於透過椎管內和硬膜外微刺激來誘導腿部運動。此外，該領域的技術進步預計將在不久的將來進一步推動市場成長。由於薦椎神經刺激（SNS）在慢性頑固性骨盆疼痛和神經源性膀胱方面的應用，預計將成為預測期內成長最快的領域。
  • 就應用領域而言，由於帕金森氏症和癲癇的增加，運動神經元疾病佔據了最大的領域。例如，根據帕金森氏症基金會2012年發布的報告，每年約有6萬名美國被診斷出患有帕金森氏症，預計這一數字在預測期內將進一步增加，隨著這一細分市場的成長正在蓬勃發展。
  • 2023年，北美佔整個神經修復市場的42.5%以上。這是由於神經植入製造商數量眾多、研發投資高以及政府和私人機構提供的資金。例如，國防高級研究計劃局 (DARPA) 和國家神經病變和中風研究所 (NIH) 與聯邦機構合作，提供資金支持進一步開發神經植入的研究和開發舉措。
  • 由於跨國醫療保健的引入以及消費者意識層級的提高，促進安全有效的醫療程序，亞太地區預計將成為成長最快的部分。
  • 由於策略聯盟和併購，預計該行業的競爭水平在預測期內仍將保持在高水準。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章神經假體市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 神經假體市場分析工具
    • 波特的分析
    • PESTEL分析

第4章神經假體市場：類型估計和趨勢分析

  • 細分儀表板
  • 神經修復市場：類型變化分析（2023/2030）
  • 運動義肢
  • 人工電子耳
  • 認知輔助器具
  • 視網膜植入

第5章神經修復市場：技術評估與趨勢分析

  • 細分儀表板
  • 神經修復市場：技術變革分析（2023/2030）
  • 深部腦部刺激（DBS）
  • 迷走神經刺激 (VNS)
  • 脊髓刺激 (SCS)
  • 薦椎神經刺激(SNS)

第6章神經修復市場：應用估算與趨勢分析

  • 細分儀表板
  • 神經修復市場：應用變化分析（2023/2030）
  • 運動神經元障礙
    • 帕金森氏症
    • 癲癇
  • 生理障礙
    • 聽力障礙
    • 眼科疾病
    • 心臟病
    • 腎臟疾病
  • 認知障礙
    • 阿茲海默症
    • 嚴重憂鬱症

第7章神經修復市場：區域估計與趨勢分析

  • 神經修復術市場佔有率：按地區分類（2023/2030）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Medtronic Plc
    • LivaNova
    • Cochlear Ltd.
    • Abbott Laboratories
    • Boston Scientific
    • NeuroPace, Inc.
    • St. Jude Medical, Inc.
    • Retina Implant AG.
    • Nervo Corp.
    • Sonova
簡介目錄
Product Code: 978-1-68038-891-6

Neuroprosthetics Market Growth & Trends:

The global neuroprosthetics market size is expected to reach USD 34.90 billion by 2030, expanding at a CAGR of 15.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years.

In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth.

Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth.

Neuroprosthetics Market Report Highlights:

  • The motor prosthetic devices segment dominated in terms of revenue share and accounted for over 42.8.0% of the market in 2023, followed by visual cochlear implants. Whereas, retinal neuroprosthetics were identified as one of the fastest growing market segment owing to the rising penetration and the increasing R&D efforts pertaining to product innovation.
  • The Spinal Cord Stimulation (SCS) segment held the largest share at over 49.2% owing to the analgesic property of the SCS therapy used in the treatment of ischemic pain, failed back surgery syndrome, and complex refractory pain syndrome. Furthermore, it finds applications in intraspinal and epidural microstimulation for inducing leg movements. In addition, technological advancements in this segment is expected to further boost market growth in the near future. The sacral Nerve Stimulation (SNS) is expected to be the fastest growing segment over the forecast period due to its applications in chronic intractable pelvic ache and neurogenic bladder.
  • In the applications segment, motor neuron disorders held the largest segment due to the rising incidences of Parkinson's disease and epilepsy. For instance, as per the report published by Parkinson's disease Foundation in 2012, approximately 60,000 Americans were diagnosed with Parkinson's disease each year and the number is expected to grow further over the forecast period thereby fueling this segment's growth.
  • In 2023, North America dominated the overall neuroprosthetics market at over 42.5% owing to the large presence of neural implants manufacturers, higher R&D investments, and the availability of funds from both government and private institutes. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH)in collaboration with the federal agencies are instrumental in providing funds to support R&D initiatives for the further development of neural implants.
  • Asia Pacific is anticipated to be the fastest growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers
  • Strategic collaborations and mergers & acquisitions are expected to keep the industry rivalry level high over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neuroprosthetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neuroprosthetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neuroprosthetics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neuroprosthetics Market: Type Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Motor Prosthetics
    • 4.3.1. Motor Prosthetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cochlear Implants
    • 4.4.1. Cochlear Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Cognitive Prosthetics
    • 4.5.1. Cognitive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Retinal Implants
    • 4.6.1. Retinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neuroprosthetics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neuroprosthetics Market: Technology Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Deep Brain Stimulation (DBS)
    • 5.3.1. Deep Brain Stimulation (DBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Vagus Nerve Stimulation (VNS)
    • 5.4.1. Vagus Nerve Stimulation (VNS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Spinal Cord Stimulation (SCS)
    • 5.5.1. Spinal Cord Stimulation (SCS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Sacral Nerve Stimulation (SNS)
    • 5.6.1. Sacral Nerve Stimulation (SNS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neuroprosthetics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neuroprosthetics Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Motor Neuron Disorders
    • 6.3.1. Motor Neuron Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Parkinson's Disease
      • 6.3.2.1. Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Epilepsy
      • 6.3.3.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Physiological Disorders
    • 6.4.1. Physiological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Auditory Disorders
      • 6.4.2.1. Auditory Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Ophthalmic Disorders
      • 6.4.3.1. Ophthalmic Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Cardiac Disorders
      • 6.4.4.1. Cardiac Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Kidney Disorders
      • 6.4.5.1. Kidney Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cognitive Disorders
    • 6.5.1. Cognitive Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Alzheimer's Disease
      • 6.5.2.1. Alzheimer's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Severe Depression
      • 6.5.3.1. Severe Depression Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neuroprosthetics Market: Regional Estimates & Trend Analysis

  • 7.1. Neuroprosthetics Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Medtronic Plc
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. LivaNova
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Cochlear Ltd.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Abbott Laboratories
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Boston Scientific
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. NeuroPace, Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. St. Jude Medical, Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Retina Implant AG.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Nervo Corp.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Sonova
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives